OBJECT: Meningioma is a disease with considerable morbidity and is more commonly diagnosed in females than in males. Hormonally related risk factors have long been postulated to be associated with meningioma risk, but no examination of these factors has been undertaken in males. METHODS: Subjects were male patients with intracranial meningioma (n = 456), ranging in age from 20 to 79 years, who were diagnosed among residents of the states of Connecticut, Massachusetts, and North Carolina, the San Francisco Bay Area, and 8 counties in Texas and matched controls (n = 452). Multivariate logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for the association between hormonal factors and meningioma risk in men. RESULTS: Use of soy and tofu products was inversely associated with meningioma risk (OR 0.50 [95% CI 0.37-0.68]). Increased body mass index (BMI) appears to be associated with an approximately 2-fold increased risk of developing meningioma in men. No other single hormone-related exposure was found to be associated with meningioma risk, although the prevalence of exposure to factors such as orchiectomy and vasectomy was very low. CONCLUSIONS: Estrogen-like exogenous exposures, such as soy and tofu, may be associated with reduced risk of meningioma in men. Endogenous estrogen-associated factors such as high BMI may increase risk. Examination of other exposures related to these factors may lead to better understanding of mechanisms and potentially to intervention.
OBJECT: Meningioma is a disease with considerable morbidity and is more commonly diagnosed in females than in males. Hormonally related risk factors have long been postulated to be associated with meningioma risk, but no examination of these factors has been undertaken in males. METHODS: Subjects were male patients with intracranial meningioma (n = 456), ranging in age from 20 to 79 years, who were diagnosed among residents of the states of Connecticut, Massachusetts, and North Carolina, the San Francisco Bay Area, and 8 counties in Texas and matched controls (n = 452). Multivariate logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for the association between hormonal factors and meningioma risk in men. RESULTS: Use of soy and tofu products was inversely associated with meningioma risk (OR 0.50 [95% CI 0.37-0.68]). Increased body mass index (BMI) appears to be associated with an approximately 2-fold increased risk of developing meningioma in men. No other single hormone-related exposure was found to be associated with meningioma risk, although the prevalence of exposure to factors such as orchiectomy and vasectomy was very low. CONCLUSIONS: Estrogen-like exogenous exposures, such as soy and tofu, may be associated with reduced risk of meningioma in men. Endogenous estrogen-associated factors such as high BMI may increase risk. Examination of other exposures related to these factors may lead to better understanding of mechanisms and potentially to intervention.
Authors: Seema A Khan; Robert T Chatterton; Nancy Michel; Michelle Bryk; Oukseub Lee; David Ivancic; Richard Heinz; Carola M Zalles; Irene B Helenowski; Borko D Jovanovic; Adrian A Franke; Maarten C Bosland; Jun Wang; Nora M Hansen; Kevin P Bethke; Alexander Dew; Margerie Coomes; Raymond C Bergan Journal: Cancer Prev Res (Phila) Date: 2012-02
Authors: Elizabeth B Claus; Lisa Calvocoressi; Melissa L Bondy; Joellen M Schildkraut; Joseph L Wiemels; Margaret Wrensch Journal: Cancer Date: 2012-04-10 Impact factor: 6.860
Authors: Joseph L Wiemels; Margaret Wrensch; Jennette D Sison; Mi Zhou; Melissa Bondy; Lisa Calvocoressi; Peter M Black; Herbert Yu; Joellen M Schildkraut; Elizabeth B Claus Journal: Int J Cancer Date: 2011-04-25 Impact factor: 7.396
Authors: Elizabeth B Claus; Lisa Calvocoressi; Melissa L Bondy; Margaret Wrensch; Joseph L Wiemels; Joellen M Schildkraut Journal: J Neurosurg Date: 2012-10-26 Impact factor: 5.115
Authors: Elizabeth B Claus; Peter M Black; Melissa L Bondy; Lisa Calvocoressi; Joellen M Schildkraut; Joseph L Wiemels; Margaret Wrensch Journal: Cancer Date: 2007-08-01 Impact factor: 6.860
Authors: Ivo S Muskens; Anna H Wu; Jacqueline Porcel; Iona Cheng; Loïc Le Marchand; Joseph L Wiemels; Veronica Wendy Setiawan Journal: Neuro Oncol Date: 2019-03-18 Impact factor: 12.300
Authors: Quinn T Ostrom; Maral Adel Fahmideh; David J Cote; Ivo S Muskens; Jeremy M Schraw; Michael E Scheurer; Melissa L Bondy Journal: Neuro Oncol Date: 2019-11-04 Impact factor: 12.300
Authors: Robert Rutkowski; Joanna Reszec; Adam Hermanowicz; Robert Chrzanowski; Tomasz Lyson; Zenon Mariak; Lech Chyczewski Journal: Oncol Lett Date: 2016-02-24 Impact factor: 2.967
Authors: Corinna Seliger; Christoph R Meier; Claudia Becker; Susan S Jick; Martin Proescholdt; Ulrich Bogdahn; Peter Hau; Michael F Leitzmann Journal: Oncotarget Date: 2017-01-10
Authors: Hannah Takahashi; Alex J Cornish; Amit Sud; Philip J Law; Linden Disney-Hogg; Lisa Calvocoressi; Lingeng Lu; Helen M Hansen; Ivan Smirnov; Kyle M Walsh; Johannes Schramm; Per Hoffmann; Markus M Nöthen; Karl-Heinz Jöckel; Joellen M Schildkraut; Matthias Simon; Melissa Bondy; Margaret Wrensch; Joseph L Wiemels; Elizabeth B Claus; Clare Turnbull; Richard S Houlston Journal: Sci Rep Date: 2019-01-22 Impact factor: 4.379
Authors: Theodoros N Sergentanis; Georgios Tsivgoulis; Christina Perlepe; Ioannis Ntanasis-Stathopoulos; Ioannis-Georgios Tzanninis; Ioannis N Sergentanis; Theodora Psaltopoulou Journal: PLoS One Date: 2015-09-02 Impact factor: 3.240